A Split Luciferase Complementation Assay for the Quantification of β-Arrestin2 Recruitment to Dopamine D
Emerald luciferase
GPCR
GRK
dopamine D2-like receptors
functional assay
β-arrestin
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
24 Aug 2020
24 Aug 2020
Historique:
received:
14
07
2020
revised:
12
08
2020
accepted:
21
08
2020
entrez:
28
8
2020
pubmed:
28
8
2020
medline:
2
3
2021
Statut:
epublish
Résumé
Investigations on functional selectivity of GPCR ligands have become increasingly important to identify compounds with a potentially more beneficial side effect profile. In order to discriminate between individual signaling pathways, the determination of β-arrestin2 recruitment, in addition to G-protein activation, is of great value. In this study, we established a sensitive split luciferase-based assay with the ability to quantify β-arrestin2 recruitment to D
Identifiants
pubmed: 32847148
pii: ijms21176103
doi: 10.3390/ijms21176103
pmc: PMC7503597
pii:
doi:
Substances chimiques
Ligands
0
Receptors, Dopamine D2
0
beta-Arrestin 2
0
Luciferases
EC 1.13.12.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : Research Training Group GRK 1910
Références
Anal Biochem. 2019 May 15;573:8-16
pubmed: 30853375
Pharmacol Res Perspect. 2015 Feb;3(1):e00073
pubmed: 25692006
Genomics. 1991 Nov;11(3):777-8
pubmed: 1774076
J Pharmacol Exp Ther. 1999 Aug;290(2):908-16
pubmed: 10411608
J Clin Invest. 1996 May 15;97(10):2283-8
pubmed: 8636408
Biochem Biophys Res Commun. 2016 Aug 5;476(4):245-251
pubmed: 27240955
Nat Neurosci. 2004 Jul;7(7):726-35
pubmed: 15195095
Life Sci. 1978 Aug 7;23(5):479-83
pubmed: 357876
Science. 1996 Jan 19;271(5247):363-6
pubmed: 8553074
J Med Chem. 2000 Feb 24;43(4):756-62
pubmed: 10691700
Anal Biochem. 2014 Mar 15;449:32-41
pubmed: 24361713
J Biol Chem. 2001 Jun 1;276(22):19452-60
pubmed: 11279203
Science. 2002 May 31;296(5573):1636-9
pubmed: 12040175
Nature. 1990 Sep 13;347(6289):146-51
pubmed: 1975644
Mol Biosyst. 2013 May;9(5):957-64
pubmed: 23302795
Neuropharmacology. 2007 Aug;53(2):232-41
pubmed: 17588617
Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18488-93
pubmed: 22025698
J Biol Chem. 2018 Apr 20;293(16):6161-6171
pubmed: 29487132
Biochem Biophys Res Commun. 2008 Feb 1;366(1):42-7
pubmed: 18036556
J Biol Chem. 1993 Nov 15;268(32):23735-8
pubmed: 8226899
J Biol Chem. 2009 May 29;284(22):15038-51
pubmed: 19332542
J Biol Chem. 2002 Mar 15;277(11):9415-21
pubmed: 11773080
Science. 1990 Jun 22;248(4962):1547-50
pubmed: 2163110
J Pharmacol Exp Ther. 2002 Nov;303(2):805-14
pubmed: 12388667
Pharmacol Rev. 2011 Mar;63(1):182-217
pubmed: 21303898
J Biol Chem. 1996 Oct 4;271(40):24907-13
pubmed: 8798768
J Pharmacol Exp Ther. 1994 Jan;268(1):417-26
pubmed: 8301582
J Biol Chem. 1982 Jun 10;257(11):6351-61
pubmed: 6176582
Pharmacol Res. 2019 May;143:48-57
pubmed: 30844536
Nature. 1990 Sep 6;347(6288):72-6
pubmed: 2144334
Eur J Biochem. 1999 Jul;263(2):596-602
pubmed: 10406971
Am J Psychiatry. 1991 Nov;148(11):1474-86
pubmed: 1681750
Eur J Biochem. 1999 Feb;260(1):112-9
pubmed: 10091590
Cell Signal. 2010 Apr;22(4):600-9
pubmed: 19932171
Bipolar Disord. 2009 Dec;11(8):787-806
pubmed: 19922550
Mol Cell Endocrinol. 1984 Jul;36(3):201-9
pubmed: 6540722
Mov Disord. 2004 Oct;19(10):1158-62
pubmed: 15390076
ACS Chem Neurosci. 2017 Mar 15;8(3):486-500
pubmed: 27801563
Sci Rep. 2018 Aug 21;8(1):12509
pubmed: 30131592
J Biol Chem. 2001 Oct 5;276(40):37409-14
pubmed: 11473130
Eur J Pharmacol. 1992 Apr 10;225(4):331-7
pubmed: 1354163
Eur J Pharmacol. 1999 Jun 30;375(1-3):13-30
pubmed: 10443561
Cell Signal. 2015 Oct;27(10):2002-13
pubmed: 26169958
Neuroreport. 1995 Jan 26;6(2):329-32
pubmed: 7756621
Mol Endocrinol. 2007 Sep;21(9):2242-54
pubmed: 17536008
J Neurochem. 1995 Feb;64(2):940-3
pubmed: 7830089
Biochem Pharmacol. 1998 Jul 1;56(1):25-30
pubmed: 9698085
Br J Pharmacol. 2013 Nov;170(5):1112-29
pubmed: 23992580
Eur J Pharmacol. 2008 Nov 12;597(1-3):27-33
pubmed: 18831971
Trends Pharmacol Sci. 1990 Jun;11(6):231-6
pubmed: 2200181
J Recept Signal Transduct Res. 2004 Aug;24(3):165-205
pubmed: 15521361
J Biol Chem. 2009 Dec 4;284(49):34103-15
pubmed: 19815545
Curr Chem Genomics. 2011;5:122-8
pubmed: 22207892
Neuropharmacology. 2008 Jun;54(8):1215-22
pubmed: 18455202
J Pharmacol Exp Ther. 1994 Jan;268(1):495-502
pubmed: 8301592
Mol Pharmacol. 2014 Jul;86(1):96-105
pubmed: 24755247
Neuropharmacology. 2004;47 Suppl 1:227-41
pubmed: 15464140
J Biol Chem. 1993 Feb 15;268(5):3201-8
pubmed: 8381421
Mov Disord. 2004 Dec;19(12):1432-8
pubmed: 15390055
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13656-61
pubmed: 18768802
Photochem Photobiol Sci. 2008 Feb;7(2):159-69
pubmed: 18264583
Pharmacol Res. 2016 Dec;114:13-26
pubmed: 27751876
Nature. 1991 Apr 18;350(6319):610-4
pubmed: 1840645
Nat Struct Mol Biol. 2018 Jan;25(1):4-12
pubmed: 29323277
Annu Rev Neurosci. 2004;27:107-44
pubmed: 15217328
Methods Mol Biol. 2019;1947:257-267
pubmed: 30969421
Anal Chem. 2010 Mar 15;82(6):2552-60
pubmed: 20180537
Psychopharmacologia. 1976 Feb 2;45(3):243-54
pubmed: 175391
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108
pubmed: 4202581
Annu Rev Physiol. 2007;69:483-510
pubmed: 17305471
J Biol Chem. 2000 Jun 2;275(22):17201-10
pubmed: 10748214
Mol Pharmacol. 2011 Aug;80(2):294-303
pubmed: 21596927
Adv Biochem Psychopharmacol. 1978;19:155-65
pubmed: 358777
Pharmacol Res. 2016 Sep;111:1-16
pubmed: 27178731
J Neurol Sci. 1973 Dec;20(4):415-55
pubmed: 4272516
Acta Psychiatr Scand Suppl. 2007;(434):41-9
pubmed: 17688462
J Med Chem. 2020 May 28;63(10):5297-5311
pubmed: 32420741
Mol Pharmacol. 1983 Mar;23(2):295-302
pubmed: 6835198